PL328228A1 - 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system - Google Patents
1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous systemInfo
- Publication number
- PL328228A1 PL328228A1 PL97328228A PL32822897A PL328228A1 PL 328228 A1 PL328228 A1 PL 328228A1 PL 97328228 A PL97328228 A PL 97328228A PL 32822897 A PL32822897 A PL 32822897A PL 328228 A1 PL328228 A1 PL 328228A1
- Authority
- PL
- Poland
- Prior art keywords
- piperidines
- indol
- pyrazol
- ethyl
- nervous system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19602505A DE19602505A1 (de) | 1996-01-25 | 1996-01-25 | 1-(Pyrazol-4-Indol-3-yl)-Piperidine |
PCT/EP1997/000187 WO1997027186A1 (de) | 1996-01-25 | 1997-01-17 | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
PL328228A1 true PL328228A1 (en) | 1999-01-18 |
Family
ID=7783568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL97328228A PL328228A1 (en) | 1996-01-25 | 1997-01-17 | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0879234A1 (hu) |
JP (1) | JP2000503972A (hu) |
KR (1) | KR19990081970A (hu) |
CN (1) | CN1209807A (hu) |
AR (1) | AR005549A1 (hu) |
AU (1) | AU715785B2 (hu) |
BR (1) | BR9707467A (hu) |
CA (1) | CA2244136A1 (hu) |
CZ (1) | CZ231898A3 (hu) |
DE (1) | DE19602505A1 (hu) |
HU (1) | HUP9900980A2 (hu) |
NO (1) | NO983439L (hu) |
PL (1) | PL328228A1 (hu) |
SK (1) | SK99298A3 (hu) |
WO (1) | WO1997027186A1 (hu) |
ZA (1) | ZA97572B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003509509A (ja) * | 1999-09-09 | 2003-03-11 | ハー・ルンドベック・アクチエゼルスカベット | 5−アミノアルキル及び5−アミノカルボニル置換されたインドール類 |
PL356487A1 (en) | 1999-11-10 | 2004-06-28 | Takeda Chemical Industries, Ltd. | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
AU2001281255B2 (en) | 2000-08-14 | 2006-07-20 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
HUP0402124A2 (hu) * | 2001-11-14 | 2005-02-28 | Merck Patent Gmbh | Pszichofarmakológiában alkalmazható pirazolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
BRPI0617204A2 (pt) | 2005-10-11 | 2011-07-19 | Hoffmann La Roche | derivados de imidazo benzodiazepina |
JP2009515833A (ja) * | 2005-10-24 | 2009-04-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター |
TWI548630B (zh) * | 2011-04-06 | 2016-09-11 | Lg生命科學有限公司 | 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶型及其製造方法 |
TW202336015A (zh) * | 2020-11-04 | 2023-09-16 | 南韓商Lg化學股份有限公司 | 唑-4-羧酸結晶之製備方法及包含彼之醫藥組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2060816C3 (de) * | 1970-12-10 | 1980-09-04 | Merck Patent Gmbh, 6100 Darmstadt | 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen |
DE2258033A1 (de) * | 1972-11-27 | 1974-05-30 | Merck Patent Gmbh | Verfahren zur herstellung von pyrazolderivaten |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
US5045550A (en) * | 1990-09-20 | 1991-09-03 | Warner-Lambert Co. | Substituted tetrahydropyridines as central nervous system agents |
US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
-
1996
- 1996-01-25 DE DE19602505A patent/DE19602505A1/de not_active Withdrawn
-
1997
- 1997-01-17 SK SK992-98A patent/SK99298A3/sk unknown
- 1997-01-17 JP JP9526493A patent/JP2000503972A/ja active Pending
- 1997-01-17 KR KR1019980705688A patent/KR19990081970A/ko not_active Application Discontinuation
- 1997-01-17 CN CN97191852A patent/CN1209807A/zh active Pending
- 1997-01-17 WO PCT/EP1997/000187 patent/WO1997027186A1/de not_active Application Discontinuation
- 1997-01-17 CA CA002244136A patent/CA2244136A1/en not_active Abandoned
- 1997-01-17 EP EP97901049A patent/EP0879234A1/de not_active Withdrawn
- 1997-01-17 BR BR9707467A patent/BR9707467A/pt unknown
- 1997-01-17 PL PL97328228A patent/PL328228A1/xx unknown
- 1997-01-17 HU HU9900980A patent/HUP9900980A2/hu unknown
- 1997-01-17 CZ CZ982318A patent/CZ231898A3/cs unknown
- 1997-01-17 AU AU14432/97A patent/AU715785B2/en not_active Ceased
- 1997-01-23 ZA ZA9700572A patent/ZA97572B/xx unknown
- 1997-01-24 AR ARP970100297A patent/AR005549A1/es unknown
-
1998
- 1998-07-24 NO NO983439A patent/NO983439L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CZ231898A3 (cs) | 1998-10-14 |
WO1997027186A1 (de) | 1997-07-31 |
CA2244136A1 (en) | 1997-07-31 |
EP0879234A1 (de) | 1998-11-25 |
CN1209807A (zh) | 1999-03-03 |
NO983439L (no) | 1998-09-25 |
AU1443297A (en) | 1997-08-20 |
DE19602505A1 (de) | 1997-07-31 |
NO983439D0 (no) | 1998-07-24 |
BR9707467A (pt) | 1999-07-20 |
AU715785B2 (en) | 2000-02-10 |
ZA97572B (en) | 1997-08-04 |
JP2000503972A (ja) | 2000-04-04 |
HUP9900980A2 (hu) | 1999-07-28 |
SK99298A3 (en) | 1999-01-11 |
AR005549A1 (es) | 1999-06-23 |
KR19990081970A (ko) | 1999-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1022149A1 (en) | N-substituted 2-cyanopyrrolidines. | |
ZA977011B (en) | Muscarinic antagonists. | |
AU2143295A (en) | Neurokinin receptor antagonists | |
GB9719141D0 (en) | Stabilizer combination | |
PL332593A1 (en) | N-substituted azaheterocyclic compounds | |
GB9605027D0 (en) | Quinoxalinediones | |
HUP0202034A3 (en) | Heterocyclic substituted aminoazacycles useful as central nervous system agents | |
GB9714129D0 (en) | Azetidines | |
HUP9904622A3 (en) | 1,4-di-sustituted piperidines as muscarinic antagonists | |
PL342732A1 (en) | 1-(heteroarylpropyl- or -prop-2-enyl)-4 benzylpiperidine as antagopnists nmda receptor | |
AU3567195A (en) | Neurokinin antagonists | |
AU2446297A (en) | Substituted piperazines and piperidines as central nervous system agents | |
HRP970006A2 (en) | Azetidines | |
HRP970302B1 (en) | Overvoltage sink | |
PL328228A1 (en) | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system | |
DE69629454D1 (en) | Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate | |
EP1021561A4 (en) | $ G (b) -ADRENERGIC RECEPTOR POLYMORPHISMS | |
IL129121A0 (en) | N-substituted azaheterocyclic compounds | |
PL334569A1 (en) | Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for treating the central nervous system | |
AU4376997A (en) | N-substituted azaheterocyclic compounds | |
HRP970094A2 (en) | 1,4-dihydropyridine compounds | |
GB2315006B (en) | Equestrian bit | |
SI0751939T1 (en) | Naphthylamides as central nervous system agents | |
ZA9710450B (en) | Suspension unit | |
IL156284A0 (en) | 1-(3, 4-dichlorophenyl)-3-[2-(2-dimethylaminoethoxy)-benzylindene]-pyrrolidin-2-one and pharmaceutical compositions containing the same |